RESUMEN
Perioperative chemotherapy (CT) and chemoradiotherapy are widely used for advanced esophageal cancer. We evaluated the chemosensitivity of patients displaying recurrent esophageal cancer after esophagectomy with perioperative CT. From the database at National Cancer Center Hospital in Tokyo, we extracted recurrent esophageal cancer cases after perioperative CT and evaluated the effectiveness of the first CT against the recurrent disease according to the duration between termination of the original perioperative CT and recurrence with treatment-free intervals (TFIs) Asunto(s)
Antineoplásicos/uso terapéutico
, Carcinoma de Células Escamosas/tratamiento farmacológico
, Carcinoma de Células Escamosas/secundario
, Neoplasias Esofágicas/tratamiento farmacológico
, Neoplasias Esofágicas/cirugía
, Anciano
, Carcinoma de Células Escamosas/cirugía
, Quimioterapia Adyuvante
, Cisplatino/uso terapéutico
, Estudios de Cohortes
, Bases de Datos Factuales
, Supervivencia sin Enfermedad
, Neoplasias Esofágicas/patología
, Esofagectomía
, Femenino
, Fluorouracilo/uso terapéutico
, Humanos
, Masculino
, Persona de Mediana Edad
, Estudios Retrospectivos